Brief: Armata Pharmaceuticals Posts Q3 Loss Per Share Of 22 Cents
10/11/2021 22:21
Nov 10 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES THIRD QUARTER RESULTS AND
PROVIDES GENERAL CORPORATE UPDATE
* ARMATA PHARMACEUTICALS INC QTRLY LOSS PER SHARE 22 CENTS
Source text for Eikon: ID:nPn1fl3G4a
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles